Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Rajani Ravi(Johns Hopkins University), Atul Bedi(Johns Hopkins University)
Nature Communications
February 15, 2018
Cited by 325


Related Papers